XtalPi introduces Kodexia AI platform for RNA drug discovery
Kodexia combines generative AI with automated laboratory testing to discover siRNA drugs, according to TechRepublic. RuntimeWire reports that co-founders Jian Ma, Shuhao Wen and Lipeng Lai are extending XtalPi's physics-and-automation approach into RNA medicines, while noting that the company's internal performance claims have yet to demonstrate their value.
- RuntimeWire reports that Kodexia covers six siRNA programs.
Covered by 2 publishers within 23 hours of the first report.
Reporting2
RuntimeWire XtalPi launches Kodexia, its platform for six siRNA programs · RuntimeWire Staff
TechRepublic XtalPi Details Kodexia AI Platform for siRNA Drug Discovery · Aminu Abdullahi